BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32979454)

  • 1. Fibroblast growth factor 2 conjugated superparamagnetic iron oxide nanoparticles (FGF2-SPIONs) ameliorate hepatic stellate cells activation in vitro and acute liver injury in vivo.
    Kurniawan DW; Booijink R; Pater L; Wols I; Vrynas A; Storm G; Prakash J; Bansal R
    J Control Release; 2020 Dec; 328():640-652. PubMed ID: 32979454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered Relaxin as theranostic nanomedicine to diagnose and ameliorate liver cirrhosis.
    Nagórniewicz B; Mardhian DF; Booijink R; Storm G; Prakash J; Bansal R
    Nanomedicine; 2019 Apr; 17():106-118. PubMed ID: 30677498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin attenuates motility, contraction, and fibrogenic response of hepatic stellate cells
    Li Z; Ding Q; Ling LP; Wu Y; Meng DX; Li X; Zhang CQ
    World J Gastroenterol; 2018 Feb; 24(7):819-832. PubMed ID: 29467552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine kinase inhibitor neratinib attenuates liver fibrosis by targeting activated hepatic stellate cells.
    Park YJ; An HT; Park JS; Park O; Duh AJ; Kim K; Chung KH; Lee KC; Oh Y; Lee S
    Sci Rep; 2020 Sep; 10(1):14756. PubMed ID: 32901093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of fibroblast growth factor type 1 and 2 in carbon tetrachloride-induced hepatic injury and fibrogenesis.
    Yu C; Wang F; Jin C; Huang X; Miller DL; Basilico C; McKeehan WL
    Am J Pathol; 2003 Oct; 163(4):1653-62. PubMed ID: 14507672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Milk Fat Globule-EGF Factor 8, Secreted by Mesenchymal Stem Cells, Protects Against Liver Fibrosis in Mice.
    An SY; Jang YJ; Lim HJ; Han J; Lee J; Lee G; Park JY; Park SY; Kim JH; Do BR; Han C; Park HK; Kim OH; Song MJ; Kim SJ; Kim JH
    Gastroenterology; 2017 Apr; 152(5):1174-1186. PubMed ID: 27956229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
    Tu X; Zhang H; Zhang J; Zhao S; Zheng X; Zhang Z; Zhu J; Chen J; Dong L; Zang Y; Zhang J
    J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular magnetic resonance imaging of activated hepatic stellate cells with ultrasmall superparamagnetic iron oxide targeting integrin αvβ₃ for staging liver fibrosis in rat model.
    Zhang C; Liu H; Cui Y; Li X; Zhang Z; Zhang Y; Wang D
    Int J Nanomedicine; 2016; 11():1097-108. PubMed ID: 27051285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CPEB4 Increases Expression of PFKFB3 to Induce Glycolysis and Activate Mouse and Human Hepatic Stellate Cells, Promoting Liver Fibrosis.
    Mejias M; Gallego J; Naranjo-Suarez S; Ramirez M; Pell N; Manzano A; Suñer C; Bartrons R; Mendez R; Fernandez M
    Gastroenterology; 2020 Jul; 159(1):273-288. PubMed ID: 32169429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FGF2 engineered SPIONs attenuate tumor stroma and potentiate the effect of chemotherapy in 3D heterospheroidal model of pancreatic tumor.
    Mardhian DF; Vrynas A; Storm G; Bansal R; Prakash J
    Nanotheranostics; 2020; 4(1):26-39. PubMed ID: 31911892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast growth factor 2 (FGF2) regulates cytoglobin expression and activation of human hepatic stellate cells via JNK signaling.
    Sato-Matsubara M; Matsubara T; Daikoku A; Okina Y; Longato L; Rombouts K; Thuy LTT; Adachi J; Tomonaga T; Ikeda K; Yoshizato K; Pinzani M; Kawada N
    J Biol Chem; 2017 Nov; 292(46):18961-18972. PubMed ID: 28916723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
    Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
    Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Periostin promotes liver fibrogenesis by activating lysyl oxidase in hepatic stellate cells.
    Kumar P; Smith T; Raeman R; Chopyk DM; Brink H; Liu Y; Sulchek T; Anania FA
    J Biol Chem; 2018 Aug; 293(33):12781-12792. PubMed ID: 29941453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone morphogenetic protein-7 represses hepatic stellate cell activation and liver fibrosis
    Zou GL; Zuo S; Lu S; Hu RH; Lu YY; Yang J; Deng KS; Wu YT; Mu M; Zhu JJ; Zeng JZ; Zhang BF; Wu X; Zhao XK; Li HY
    World J Gastroenterol; 2019 Aug; 25(30):4222-4234. PubMed ID: 31435175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sauchinone attenuates liver fibrosis and hepatic stellate cell activation through TGF-β/Smad signaling pathway.
    Lee JH; Jang EJ; Seo HL; Ku SK; Lee JR; Shin SS; Park SD; Kim SC; Kim YW
    Chem Biol Interact; 2014 Dec; 224():58-67. PubMed ID: 25451574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular crosstalk mediated by platelet-derived growth factor BB and transforming growth factor β during hepatic injury activates hepatic stellate cells.
    Mekala S; Tulimilli SV; Geesala R; Manupati K; Dhoke NR; Das A
    Can J Physiol Pharmacol; 2018 Aug; 96(8):728-741. PubMed ID: 29558627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymosin β4 suppresses CCl
    Li H; Li Q; Zhang X; Zheng X; Zhang Q; Hao Z
    J Gene Med; 2018 Sep; 20(9):e3043. PubMed ID: 29972714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of hepatic stellate cell activation using JQ1- and atorvastatin-loaded chitosan nanoparticles as a promising approach in therapy of liver fibrosis.
    Hassan R; Tammam SN; Safy SE; Abdel-Halim M; Asimakopoulou A; Weiskirchen R; Mansour S
    Eur J Pharm Biopharm; 2019 Jan; 134():96-106. PubMed ID: 30471341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Docosahexaenoic acid attenuates carbon tetrachloride-induced hepatic fibrosis in rats.
    He J; Bai K; Hong B; Zhang F; Zheng S
    Int Immunopharmacol; 2017 Dec; 53():56-62. PubMed ID: 29035816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting ER protein TXNDC5 in hepatic stellate cell mitigates liver fibrosis by repressing non-canonical TGFβ signalling.
    Hung CT; Su TH; Chen YT; Wu YF; Chen YT; Lin SJ; Lin SL; Yang KC
    Gut; 2022 Sep; 71(9):1876-1891. PubMed ID: 34933915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.